Literature DB >> 17348658

Circumventing anti-androgen resistance by molecular design.

Paula L McGinley1, John T Koh.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17348658      PMCID： PMC2546518          DOI： 10.1021/ja0701154

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  9 in total

Review 1.  Nuclear-receptor ligands and ligand-binding domains.

Authors:  R V Weatherman; R J Fletterick; T S Scanlan
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Collocation of androgen receptor gene mutations in prostate cancer.

Authors:  G Buchanan; N M Greenberg; H I Scher; J M Harris; V R Marshall; W D Tilley
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

Review 3.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

4.  Structural basis for antagonism and resistance of bicalutamide in prostate cancer.

Authors:  Casey E Bohl; Wenqing Gao; Duane D Miller; Charles E Bell; James T Dalton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-15       Impact factor: 11.205

5.  Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.

Authors:  M E Taplin; G J Bubley; Y J Ko; E J Small; M Upton; B Rajeshkumar; S P Balk
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

Review 6.  Alterations of androgen receptor in prostate cancer.

Authors:  Marika J Linja; Tapio Visakorpi
Journal:  J Steroid Biochem Mol Biol       Date:  2004-12-19       Impact factor: 4.292

7.  Nuclear receptor antagonists designed based on the helix-folding inhibition hypothesis.

Authors:  Yuichi Hashimoto; Hiroyuki Miyachi
Journal:  Bioorg Med Chem       Date:  2005-09-01       Impact factor: 3.641

Review 8.  Transition to androgen-independence in prostate cancer.

Authors:  Domingo Navarro; Octavio P Luzardo; Leandro Fernández; Nicolás Chesa; Bonifacio N Díaz-Chico
Journal:  J Steroid Biochem Mol Biol       Date:  2002-07       Impact factor: 4.292

Review 9.  Targeting steroid hormone receptor pathways in the treatment of hormone dependent cancers.

Authors:  Y J Ko; S P Balk
Journal:  Curr Pharm Biotechnol       Date:  2004-10       Impact factor: 2.837
  9 in total
  8 in total

1.  Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target.

Authors:  Yu Chen; Nicola J Clegg; Howard I Scher
Journal:  Lancet Oncol       Date:  2009-10       Impact factor: 41.316

2.  Androgen receptor antagonism by divalent ethisterone conjugates in castrate-resistant prostate cancer cells.

Authors:  Paul M Levine; Eugine Lee; Alex Greenfield; Richard Bonneau; Susan K Logan; Michael J Garabedian; Kent Kirshenbaum
Journal:  ACS Chem Biol       Date:  2012-08-07       Impact factor: 5.100

Review 3.  Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance.

Authors:  John A Katzenellenbogen; Christopher G Mayne; Benita S Katzenellenbogen; Geoffrey L Greene; Sarat Chandarlapaty
Journal:  Nat Rev Cancer       Date:  2018-06       Impact factor: 60.716

Review 4.  The Bump-and-Hole Tactic: Expanding the Scope of Chemical Genetics.

Authors:  Kabirul Islam
Journal:  Cell Chem Biol       Date:  2018-08-02       Impact factor: 8.116

5.  Synthesis and in vitro characterization of ionone-based chalcones as novel antiandrogens effective against multiple clinically relevant androgen receptor mutants.

Authors:  Jinming Zhou; Guoyan Geng; Jian Hui Wu
Journal:  Invest New Drugs       Date:  2009-04-24       Impact factor: 3.850

Review 6.  Androgen receptor: structure, role in prostate cancer and drug discovery.

Authors:  M H Eileen Tan; Jun Li; H Eric Xu; Karsten Melcher; Eu-leong Yong
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

Review 7.  Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance.

Authors:  Xiaohong Tian; Yang He; Jinming Zhou
Journal:  Front Pharmacol       Date:  2015-03-24       Impact factor: 5.810

8.  Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction.

Authors:  Joel Wahl; Martin Smieško
Journal:  Int J Mol Sci       Date:  2018-06-15       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.